心脏再同步化治疗在儿童心力衰竭中应用

doi:10.12372/jcp.2024.22e1661

Abstract

Abstract:

As an important non-drug treatment for heart failure in adults, cardiac resynchronization therapy (CRT) is gaining more and more interest and application in pediatric heart failure, and it has been preliminarily proved to be effective in heart failure due to some etiologies. This article reviews the application, efficacy, implantation forms and adverse reactions of CRT in children with heart failure caused by different causes such as congenital heart disease and pace-induced cardiomyopathy in recent years, and looks forward to the further development of CRT, in order to provide reference for timely application of CRT in children with heart failure.

Key words: heart failure, cardiac resynchronization therapy, child

CHEN Ruoyu, LYU Tiewei. Cardiac resynchronization therapy in children with heart failure[J].Journal of Clinical Pediatrics, 2024, 42(4): 367-372.

References 28

[1]	中华医学会儿科学分会心血管学组, 中国医师协会心血管内科医师分会儿童心血管专业委员会, 中华儿科杂志编辑委员会. 儿童心力衰竭诊断和治疗建议(2020年修订版)[J]. 中华儿科杂志, 2021, 59(2): 84-94.
[2]	Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy[J]. Eur Heart J, 2021, 42(35): 3427-3520. doi: 10.1093/eurheartj/ehab364 pmid: 34455430
[3]	Motonaga KS, Dubin AM. Cardiac resynchronization therapy for pediatric patients with heart failure and congenital heart disease: a reappraisal of results[J]. Circulation, 2014, 129(18): 1879-1891. doi: 10.1161/CIRCULATIONAHA.113.001383 pmid: 24799504
[4]	Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. Circulation, 2022, 145(18): e876-e894. doi: 10.1161/CIR.0000000000001062 pmid: 35363500
[5]	张蕾, 田杰. 儿童心力衰竭的非药物治疗进展[J]. 中华实用儿科临床杂志, 2021, 36(13): 971-975.
[6]	Kubuš P, Rubáčková Popelová J, Kovanda J, et al. Long-term outcome of patients with congenital heart disease undergoing cardiac resynchronization therapy[J]. J Am Heart Assoc, 2021, 10(6): e018302. doi: 10.1161/JAHA.120.018302
[7]	Shaddy RE, George AT, Jaecklin T, et al. Systematic literature review on the incidence and prevalence of heart failure in children and adolescents[J]. Pediatr Cardiol, 2018, 39(3): 415-436. doi: 10.1007/s00246-017-1787-2 pmid: 29260263
[8]	Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study[J]. J Am Coll Cardiol, 2005, 46(12): 2277-2283. pmid: 16360058
[9]	Chubb H, Rosenthal DN, Almond CS, et al. Impact of cardiac resynchronization therapy on heart transplant-free survival in pediatric and congenital heart disease patients[J]. Circ Arrhythm Electrophysiol, 2020, 13(4): e007925.
[10]	Somma V, Ha FJ, Palmer S, et al. Pacing-induced cardiomyopathy: a systematic review and meta-analysis of definition, prevalence, risk factors, and management[J]. Heart Rhythm, 2023, 20(2): 282-290. doi: 10.1016/j.hrthm.2022.09.019
[11]	Janoušek J, van Geldorp IE, Krupičková S, et al. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study[J]. Circulation, 2013, 127(5): 613-623. doi: 10.1161/CIRCULATIONAHA.112.115428 pmid: 23275383
[12]	刘甜, 梁东坡, 张智伟, 等. 儿童右心室起搏致心力衰竭后升级心脏再同步治疗五例长期随访[J]. 中华儿科杂志, 2019, 57(4): 281-285.
[13]	Tsujii N, Miyazaki A, Sakaguchi H, et al. High incidence of dilated cardiomyopathy after right ventricular inlet pacing in patients with congenital complete atrioventricular block[J]. Circ J, 2016, 80(5): 1251-1258. doi: 10.1253/circj.CJ-15-1122 pmid: 27008922
[14]	Cioffi GM, Gasperetti A, Tersalvi G, et al. Etiology and device therapy in complete atrioventricular block in pediatric and young adult population: Contemporary review and new perspectives[J]. J Cardiovasc Electrophysiol, 2021, 32(11): 3082-3094. doi: 10.1111/jce.v32.11
[15]	Rupp S, Jux C. Advances in heart failure therapy in pediatric patients with dilated cardiomyopathy[J]. Heart Fail Rev, 2018, 23(4): 555-562. doi: 10.1007/s10741-018-9692-1 pmid: 29564593
[16]	Kim DH, Choi ES, Kwon BS, et al. Development of cardiac events and functional recovery prediction models for pediatric dilated cardiomyopathy[J]. Front Pediatr, 2021, 9: 736872. doi: 10.3389/fped.2021.736872
[17]	Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates[J]. Heart, 2009, 95(14): 1165-1171. doi: 10.1136/hrt.2008.160465 pmid: 19307198
[18]	Sun S, Guo X, Chen Y, et al. Left ventricular epicardial pacing achieved hyper-responsiveness in young children with dilated cardiomyopathy with left bundle branch block[J]. ESC Heart Fail, 2021, 8(6): 4772-4779. doi: 10.1002/ehf2.13657 pmid: 34729942
[19]	Ergul Y, Sevinc Sengul F, Öztürk E, et al. Cardiac resynchronization therapy in paediatric patients with congenital heart disease: single centre with 10 years of experience[J]. Cardiol Young, 2021, 31(6): 940-948. doi: 10.1017/S1047951120004795 pmid: 33500007
[20]	陈轶维, 赵文婥, 王顺民, 等. 膜部室间隔缺损封堵术后完全性左束支传导阻滞治疗效果分析[J]. 临床儿科杂志, 2020, 38(2): 123-128.
[21]	Hill AC, Silka MJ, Bar-Cohen Y. Cardiac resynchronization therapy in pediatrics[J]. J Innov Card Rhythm Manag, 2018, 9(8): 3256-3264.
[22]	Mah DY, O'Leary ET, Harrild DM, et al. Resynchronizing right and left ventricles with right bundle branch block in the congenital heart disease population[J]. JACC Clin Electrophysiol, 2020, 6(14): 1762-1772. doi: 10.1016/j.jacep.2020.06.006
[23]	Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution[J]. J Cardiovasc Electrophysiol, 2009, 20(1): 58-65. doi: 10.1111/jce.2008.20.issue-1
[24]	Chubb H, Bulic A, Mah D, et al. Impact and modifiers of ventricular pacing in patients with single ventricle circulation[J]. J Am Coll Cardiol, 2022, 80(9): 902-914. doi: 10.1016/j.jacc.2022.05.053 pmid: 36007989
[25]	Piccini JP, Russo AM, Sharma PS, et al. Advances in cardiac electrophysiology[J]. Circ Arrhythm Electrophysiol, 2022, 15(12): e009911.
[26]	Linde C. Cardiac resynchronization in heart failure: recent advances and their practical implications[J]. Kardiol Pol, 2023, 81(1): 7-13. doi: 10.33963/KP.a2023.0020 pmid: 36744912
[27]	Linhart M, Doltra A, Acosta J, et al. Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy[J]. Europace, 2020, 22(9): 1391-1400. doi: 10.1093/europace/euaa142 pmid: 32898254
[28]	Liang Y, Wang J, Gong X, et al. Left bundle branch pacing versus biventricular pacing for acute cardiac resynchronization in patients with heart failure[J]. Circ Arrhythm Electrophysiol, 2022, 15(11): e011181.

Cardiac resynchronization therapy in children with heart failure

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 28

Related Articles 15

Metrics

Comments

Recommended 0

[1]	LIN Jinfeng, CHEN Yi, DENG Yan, FENG Ai, HUANG Juan, CHEN Lizhu, XIE Jingqi, NIE Xiaojing. A comparative study on the detection of anti-Nephrin antibodies in children's nephrotic syndrome by chemiluminescence method and cell-based assay [J]. Journal of Clinical Pediatrics, 2026, 44(8): 682-689.
[2]	ZHENG Fangyuan, WANG Miao, DING Mingming, LU Aidong, JIA Yueping, ZENG Huimin, ZHANG Leping. Next-generation sequencing identified gene variants and their prognostic impact in pediatric Philadelphia chromosome positive acute lymphoblastic leukemia [J]. Journal of Clinical Pediatrics, 2026, 44(8): 690-697.
[3]	ZHANG Xiao, FANG Hongjun, KUANG Xiaojun, WANG Lijuan, WU Zhao, JIANG Sha, LI Pei, WU Liwen. Analysis of the clinical and electrophysiological characteristics of atonic seizures in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 698-704.
[4]	WANG Mengqian, YANG Hui. Case series analysis of 13 intestinal Behcet’s syndrome in children [J]. Journal of Clinical Pediatrics, 2026, 44(8): 705-711.
[5]	WU Xirong, GAO Qi, GUO Siyuan, YIN Qingqin, QIN Qiang, YIN Ju, JIAO Anxia, CHEN Chenghao, WU Di, WANG Bei, DUAN Xiaomin, PENG Yun, XU Baoping, GAO Liwei. Clinical characteristics and prognosis of pulmonary mucormycosis in children with diabetes mellitus [J]. Journal of Clinical Pediatrics, 2026, 44(8): 712-720.
[6]	HAN Yanan, GE Lanlan, CUI Jieyuan. A case report of branchio-oto-renal syndrome caused by EYA1 gene variant with a 6-year follow-up [J]. Journal of Clinical Pediatrics, 2026, 44(8): 721-726.
[7]	SHI Jiayi, GAO Chunlin, JIA Lili, LU Yunyun, SUN Tao, ZHU Xiaodong, XIA Zhengkun, ZHANG Pei. Phenotypic characteristics and prognostic analysis of a pedigree with childhood isolated nephrotic syndrome caused by compound heterozygous mutations in the COQ2 gene [J]. Journal of Clinical Pediatrics, 2026, 44(8): 727-732.
[8]	Rachel Rosen, Osvaldo Borrelli, Christophe Faure, Katja Karrento, Usha Krishnan, Samuel Nurko, Nathalie Rommel, Alan Silverman, Michiel van Wijk, Marc Benninga (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: upper gastrointestinal disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 595-608.
[9]	Carlo Di Lorenzo, Miguel Saps, Bruno P. Chumpitazi, Shaman Rajindrajith, Annamaria Staiano, Nikhil Thapar, Miranda van Tilburg, Carlos Velasco-Benítez, Arine Vlieger (Author), Chinese Medical Association Parenteral and Enteral Nutrition Branch Pediatrics Group, The Subspecialty Group of Gastroenterology, The Society of Pediatric, Chinese Medical Association, Gastroenterology Group, Pediatrician Branch, Chinese Medical Doctor Association (Translator). Core interpretation and explanation of Rome Ⅴ diagnostic criteria: lower and biliary disorders of gut-brain interaction in children and adolescents [J]. Journal of Clinical Pediatrics, 2026, 44(7): 609-621.
[10]	LI Xufeng, TANG Haoxun, LI Xingjun, ZHANG Lize, GAO Chenqing, ZHAO Shunying, LIU Jianhua. Clinical characteristics, chest CT imaging phenotypes, and their correlation with prognosis in 76 children with Chlamydia pneumoniae pneumonia [J]. Journal of Clinical Pediatrics, 2026, 44(7): 622-627.
[11]	WANG Zhen, SHAO Jingbo, ZHANG Na, XIA Min, ZHU Jiashi, DU Chengkan, LI Hong. Factors influencing long-term recurrence in pediatric acute lymphoblastic leukemia patients with low-risk disease at initial diagnosis: a five-year follow-up analysis of 254 cases from a single center [J]. Journal of Clinical Pediatrics, 2026, 44(7): 628-635.
[12]	GUO Xuemei, XUE Yao, WANG Yongren, RONG Liucheng, FANG Yongjun, LIN Rufeng. Clinical features and prognosis of childhood acute myeloid leukemia with CBFA2T3::GLIS2 fusion [J]. Journal of Clinical Pediatrics, 2026, 44(7): 636-643.
[13]	YANG Lijun, FU Dongxia, CUI Yan, YANG Junmei, ZHANG Liming. Clinical manifestation and genetic analysis of CHARGE syndrome caused by CHD7 gene variation [J]. Journal of Clinical Pediatrics, 2026, 44(7): 644-650.
[14]	HU Yan, YANG Fan, LIANG Aimin, MAO Meng. Identification and management of faltering growth in children: insights from the 13th International Conference on Nutrition and Growth [J]. Journal of Clinical Pediatrics, 2026, 44(6): 485-488.
[15]	LIU Ziyao, WANG Congying, WANG Hongmao, ZHANG Mingming, XU Yingjie, LAI Jianming, NIU Wenquan, LI Xiaohui. Early differentiation of Kawasaki disease with joint symptoms and systemic juvenile idiopathic arthritis with Kawasaki disease-like symptoms: a single-center retrospective study [J]. Journal of Clinical Pediatrics, 2026, 44(6): 489-498.